Business Description
Venmax Drugs & Pharmaceuticals Ltd
ISIN : INE154G01022
Compare
Compare
Traded in other countries / regions
531015.India IPO Date
1995-08-21Description
Venmax Drugs & Pharmaceuticals Ltd is engaged in the manufacturing and sale of bulk drugs. The company has only one operating segment which is Drugs.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -7.99 | |||||
Debt-to-Equity | -0.54 | |||||
Debt-to-EBITDA | 3.74 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year FCF Growth Rate | -80.1 | |||||
3-Year Book Growth Rate | 38.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.02 | |||||
Quick Ratio | 0.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.83 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | Neg. Equity | |||||
ROA % | 34.1 | |||||
ROIC % | -12.65 | |||||
ROC (Joel Greenblatt) % | 184.31 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 34.83 | |||||
PE Ratio without NRI | 34.83 | |||||
Price-to-Free-Cash-Flow | 1045 | |||||
Price-to-Operating-Cash-Flow | 1045 | |||||
EV-to-EBIT | 29.22 | |||||
EV-to-EBITDA | 26.99 | |||||
EV-to-FCF | 1154.32 | |||||
Price-to-Projected-FCF | 1.9 | |||||
Earnings Yield (Greenblatt) % | 3.42 | |||||
FCF Yield % | 0.1 |